Health care services utilization stratified by virological and immunological markers of HIV: evidence from a universal health care setting |
| |
Authors: | EF Druyts B Yip VD Lima TA Burke D Lesovski KA Fernandes CW McInnes CA Rustad JSG Montaner RS Hogg |
| |
Affiliation: | British Columbia Centre for Excellence in HIV/AIDS, St Paul's Hospital, Vancouver, Canada,;Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada,;Merck and Co. Inc., Whitehouse Station, NJ, USA and;Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada |
| |
Abstract: | Objective The aim of the study was to determine rates of utilization of in‐patient, out‐patient and laboratory services stratified by virological and immunological markers of HIV disease among patients on antiretroviral treatment in British Columbia, Canada. Methods We estimated resource utilization for in‐patient visits, out‐patient visits, and laboratory tests among patients initiating antiretroviral treatment between 1 April 1994 and 31 December 2000, with follow‐up to 31 March 2001. Resource use was stratified by CD4 cell count and plasma HIV viral load (pVL) at the time of utilization and rates per 100 patient‐years were calculated for each health care resource. Results A total of 2718 patients were included in our analyses. The overall rates of in‐patient visits, out‐patient visits, and laboratory tests were 902, 3001 and 840 per 100 patient‐years, respectively. Utilization was higher for patients with low CD4 cell counts and high pVLs when compared with patients with high CD4 cell counts and low pVLs. Conclusions Patients with low CD4 cell counts and high pVLs had the highest use of health care services. Regular follow‐up with health care providers in an out‐patient setting, allowing for proper monitoring and maintenance of HIV care, is important in minimizing unnecessary and potentially costly in‐patient care. |
| |
Keywords: | antiretroviral therapy health care utilization HIV/AIDS |
|
|